BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 17897004)

  • 1. 5-hydroxytryptamine (5-HT) receptor ligands.
    Kitson SL
    Curr Pharm Des; 2007; 13(25):2621-37. PubMed ID: 17897004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacology and Therapeutic Potential of the 5-HT
    Blattner KM; Canney DJ; Pippin DA; Blass BE
    ACS Chem Neurosci; 2019 Jan; 10(1):89-119. PubMed ID: 30020772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arylpiperazine derivatives acting at 5-HT(1A) receptors.
    López-Rodríguez ML; Ayala D; Benhamú B; Morcillo MJ; Viso A
    Curr Med Chem; 2002 Feb; 9(4):443-69. PubMed ID: 11945120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural insight into the serotonin (5-HT) receptor family by molecular docking, molecular dynamics simulation and systems pharmacology analysis.
    Wang YQ; Lin WW; Wu N; Wang SY; Chen MZ; Lin ZH; Xie XQ; Feng ZW
    Acta Pharmacol Sin; 2019 Sep; 40(9):1138-1156. PubMed ID: 30814658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dimers of 5HT1 ligands preferentially bind to 5HT1B/1D receptor subtypes.
    Perez M; Jorand-Lebrun C; Pauwels PJ; Pallard I; Halazy S
    Bioorg Med Chem Lett; 1998 Jun; 8(11):1407-12. PubMed ID: 9871775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigations on the 1-(2-biphenyl)piperazine motif: identification of new potent and selective ligands for the serotonin(7) (5-HT(7)) receptor with agonist or antagonist action in vitro or ex vivo.
    Lacivita E; Patarnello D; Stroth N; Caroli A; Niso M; Contino M; De Giorgio P; Di Pilato P; Colabufo NA; Berardi F; Perrone R; Svenningsson P; Hedlund PB; Leopoldo M
    J Med Chem; 2012 Jul; 55(14):6375-80. PubMed ID: 22738316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential modulation by GTPgammaS of agonist and inverse agonist binding to h5-HT(1A) receptors revealed by [3H]-WAY100,635.
    Newman-Tancredi A; Verrièle L; Millan MJ
    Br J Pharmacol; 2001 Jan; 132(2):518-24. PubMed ID: 11159702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Latest advances towards the discovery of 5-HT(7) receptor ligands.
    Pittala V; Pittala D
    Mini Rev Med Chem; 2011 Nov; 11(13):1108-21. PubMed ID: 22353220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin receptors and therapeutics.
    Launay JM; Callebert J; Bondoux D; Loric S; Maroteaux L
    Cell Mol Biol (Noisy-le-grand); 1994 May; 40(3):327-36. PubMed ID: 7522716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visualization of 5-HT Receptors Using Radioligand-Binding Autoradiography.
    Cortés R; Vilaró MT; Mengod G
    Curr Protoc Pharmacol; 2016 Dec; 75():8.3.1-8.3.20. PubMed ID: 27960027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonin 5-HT3 and 5-HT4 ligands: an update of medicinal chemistry research in the last few years.
    Modica MN; Pittalà V; Romeo G; Salerno L; Siracusa MA
    Curr Med Chem; 2010; 17(4):334-62. PubMed ID: 20015043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for presynaptic location of inhibitory 5-HT1D beta-like autoreceptors in the guinea-pig brain cortex.
    Bühlen M; Fink K; Böing C; Göthert M
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Feb; 353(3):281-9. PubMed ID: 8692282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular biology of 5-HT receptors.
    Hannon J; Hoyer D
    Behav Brain Res; 2008 Dec; 195(1):198-213. PubMed ID: 18571247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The binding of arylguanidines at 5-HT(3) serotonin receptors: a structure-affinity investigation.
    Dukat M; Choi YN; Teitler M; Du Pre A; Herrick-Davis K; Smith C; Glennon RA
    Bioorg Med Chem Lett; 2001 Jun; 11(12):1599-603. PubMed ID: 11412989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A synthetic overview of new molecules with 5-HT1A binding affinities.
    Pessoa-Mahana H; Araya-Maturana R; Saitz CB; Pessoa-Mahana DC
    Mini Rev Med Chem; 2003 Mar; 3(2):77-93. PubMed ID: 12570842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New insight into the therapeutic role of 5-HT1A receptors in central nervous system disorders.
    Ohno Y
    Cent Nerv Syst Agents Med Chem; 2010 Jun; 10(2):148-57. PubMed ID: 20518729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 5-HT1A receptor and its ligands: structure and function.
    Olivier B; Soudijn W; van Wijngaarden I
    Prog Drug Res; 1999; 52():103-65. PubMed ID: 10396127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemical update on the potential for serotonin 5-HT
    Kucwaj-Brysz K; Baltrukevich H; Czarnota K; Handzlik J
    Bioorg Med Chem Lett; 2021 Oct; 49():128275. PubMed ID: 34311086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting 5-HT receptors for the treatment of obesity.
    Sargent BJ; Henderson AJ
    Curr Opin Pharmacol; 2011 Feb; 11(1):52-8. PubMed ID: 21330209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonin receptors: subtypes, functional responses and therapeutic relevance.
    Saxena PR
    Pharmacol Ther; 1995 May; 66(2):339-68. PubMed ID: 7667401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.